Could the inhibition of systemic NLRP3 inflammasome mediate central redox effects of yerba mate? An in silico and pre-clinical translational approach

dos Santos, JM; Touguinha, L; Bridi R.; Andreazza, AC; Bick, DLU; Davidson, CB; dos Santos, AF; Machado, KA; Scariot, FJ; Delamare, LAP; Salvador, M; Branco, CS

Keywords: neuroinflammation, Ilex paraguariensis, THP-1, network pharmacology, BV-2

Abstract

Ethnopharmacological relevance: Empirically, Ilex paraguariensis A. St. Hil, or yerba-mate, has been used by natives of South America as a stimulant. Nowadays, this plant has gained popularity due to its neuroprotective effects. However, there are few studies on the biochemical-molecular mechanisms of action involved in its effect. Aim of the study: Chemically characterize an aqueous extract of yerba mate (YME) and evaluate if it could suppress the aberrant inflammatory response related to neurodegeneration. Materials and methods: Macrophages and microglia cells were exposed to lipopolysaccharide (LPS; 100 ng/mL) plus nigericin (100 mu M) or quinolinic acid (QA; 5 mM). Cellular viability, oxidative, and inflammatory markers were evaluated. Chemical matrix (HPLC - DAD), antioxidant activity, safety profile in vitro and in vivo, and an in silico docking of main targets were also assessed. Results: Pre-treatment with YME (15 mu g/mL) prevented impairments in redox metabolism and inflammatory markers in BV-2 cells. In macrophages, YME showed similar results to MCC950, an inflammasome inhibitor. YME presented 282.88 mg EAG/g total phenolic content and a redox capacity of 32.94 +/- 1.30 mu g/mL (IC50), and its major compounds were chlorogenic acid > rutin > ferulic acid > catechin > sinapic acid. Chlorogenic acid and rutin presented a high affinity to the MCC950 region. Additionally, YME did not cause genotoxicity and was safe in vivo. Conclusion: YME has significantly affected macrophages and microglia by regulating the NLRP3 inflammatory pathway.

Más información

Título según WOS: Could the inhibition of systemic NLRP3 inflammasome mediate central redox effects of yerba mate? An in silico and pre-clinical translational approach
Volumen: 344
Fecha de publicación: 2025
Idioma: English
DOI:

10.1016/j.jep.2025.119518

Notas: ISI